Schall Thomas J.'s Form 4 filing
Immuneering Corp (IMRX) · filed Jun 30, 2025
- Accession no.
- 0001790340-25-000089
- Filed
- Jun 30, 2025
- Trade date
- Jun 27, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $34.8K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schall Thomas J.CIK 0001423084 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | Class A Common Stock | PPurchaseAcquired | +9,500 | $3.66 | +$34,770 | 52,885 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.